US Patent Issued to YUHAN on Oct. 27 for "Use of long-acting FGF21 fusion proteins in treating FGF21-associated disorders" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,311, issued on Oct. 27, was assigned to YUHAN Corp. (Seoul, South Korea).

"Use of long-acting FGF21 fusion proteins in treating FGF21-associated disorders" was invented by Jun Hwan Kim (Seoul, South Korea), Seyoung Lim (Yongin-si, South Korea), Minji Seo (Seoul, South Korea), Hyun Ho Choi (Suwon-si, South Korea), Dohoon Kim (Yongin-si, South Korea), Mi Kyeong Ju (Suwon-si, South Korea), Ju-Young Park (Seoul, South Korea), Byung Hyun Choi (Suwon-si, South Korea), Jun Kyung Lee (Suwon-si, South Korea), Jong Gyun Kim (Anyang-si, South Korea) and Su Youn Nam (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A fusion protein contains an ...